The rate of TROP2 positivity was markedly lower than for EpCAM in testicular germ cell tumors, neuroendocrine neoplasms, renal cell tumors, and also in many gastrointestinal adenocarcinomas. The gene discussed is EPCAM; the disease is testicular germ cell tumor.